Meeder Asset Management Inc Corbus Pharmaceuticals Holdings, Inc. Transaction History

Meeder Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 11, 2020	SELL	$4.79 - $8.39 $6,294 - $11,024	-1,314 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$3.44 - $7.21 $4,520 - $9,473	1,314 New	1,314 $7,000
Q2 2019 Aug 05, 2019	SELL	$6.6 - $7.8 $6,751 - $7,979	-1,023 Closed	0 $0
Q1 2019 Apr 16, 2019	BUY	$5.76 - $8.95 $3,450 - $5,361	599 Added 141.27%	1,023 $7,000
Q4 2018 Jan 17, 2019	SELL	$5.26 - $7.97 $3,024 - $4,582	-575 Reduced 57.56%	424 $2,000
Q3 2018 Nov 02, 2018	BUY	$4.65 - $7.95 $4,645 - $7,942	999 New	999 $0
Q2 2018 Jul 24, 2018	SELL	$5.05 - $6.8 $1,605 - $2,162	-318 Closed	0 $0
Q1 2018 May 03, 2018	BUY	$5.6 - $9.25 $688 - $1,137	123 Added 63.08%	318 $2,000
Q4 2017 Feb 02, 2018	BUY	$6.6 - $7.78 $1,287 - $1,517	195	195 $1,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $1.79B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.